Locations:
Search IconSearch

Researchers Discover Differences in Protein Makeup of Male vs. Female Retinas

Preclinical study shows why it’s critical to consider sex in eye disease research

A woman's eye next to a man's eye

Researchers at Cleveland Clinic Cole Eye Institute have published a first-of-its-kind database of sex-based differences in the retina and retinal pigment epithelium (RPE).

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The preclinical study, published in Biology of Sex Differences, illustrates why it is critical to consider sex in research around eye disease, says senior author Bela Anand-Apte, MBBS, PhD, MBA, Chair of Ophthalmic Research at the Cole Eye Institute.

Sex as a risk factor for eye disease

Research on sex as a risk factor for age-related macular degeneration has been controversial, with a few studies showing higher prevalence in older women. In addition, preclinical studies consistently demonstrate that males are at higher risk of developing diabetes-related retinopathy when compared with females. The exact mechanisms behind these differences are unclear.

“It is commonly believed that if you manage your diabetes, you avoid diabetic retinopathy, but many people who have good control of their diabetes still get damage to their retina and RPE,” Dr. Anand-Apte says. “The fact that females seem to be more resistant to diabetic retinopathy was intriguing and inspired me to start at square one, before the disease even begins.”

Comparing number of proteins

Dr. Anand-Apte teamed up with Belinda Willard, PhD, Director of Cleveland Clinic's Proteomics and Metabolomics Core, to see if there were differences between sexes within the proteome, the entire set of proteins produced in the retina and RPE.

Most researchers will use qualitative proteomics to look for proteins that are either present or absent in one group. Drs. Anand-Apte and Willard performed quantitative proteomics, which can quantify differences in the number of proteins between samples.

“Dr. Willard’s team was essential in making this research happen — we couldn’t have done it anywhere else,” Dr. Anand-Apte says. “In fact, few researchers have this capability.”

Advertisement

The research team discovered that there are innate differences in the protein makeup of RPE and retinal cells between male and female preclinical models. There were 21 differentially expressed proteins in the retina, signaling differentially activated pathways, such as nucleotide excision repair, molecular transport, and cell death and survival. There were 58 differentially expressed proteins in the RPE, signaling differentially activated pathways, such as calcium signaling, actin cytoskeletal signaling, and cellular assembly and organization.

Next step: Exploring differences in eye disease progression

These data will help Dr. Anand-Apte and her team investigate their next question: Can we connect differences in how eye disease progresses to these baseline differences in proteins?

“These data are meant to be a tool for the research community to identify the reasons behind discrepancies in how eye disease progresses,” Dr. Anand-Apte says. “We’re beginning to gather the clues necessary for personalized treatment.”

Advertisement

Related Articles

23-EYE-4196362-inflammation-retinal-regeneration-CQD-Hero
Could Inflammation Be the Reason Why Human Retinas Don’t Regenerate?

Researchers to study retinal regeneration in zebrafish with new grant from National Eye Institute

Fluorescein angiography image of leaking blood vessels
Sickle Cell Disease Increases Risk of Retinal Vascular Occlusion

Watch for sudden unilateral vision loss without pain

OCT scan showing dry AMD
Autoimmune Disease Linked With Higher Risk of Macular Degeneration

Early data show risk is 73% higher in patients with lupus, 40% higher in patients with rheumatoid arthritis

23-EYE-4051658-CQD-ChatGPT-in-Ophthalmology-Research
Don’t Believe Everything Chatbots Say About Ophthalmic Research

30% of references generated by ChatGPT don’t exist, according to one study

22-EYE-3066210 CQD-Losartan for corneal fibrosis-Wilson-hero
Hypertension Drug Losartan Reverses Scarring and Restores Vision After Cornea Damage

Studies indicate dramatic results when used topically with or without corticosteroids

22-EYE-3141638 CQD-EYP-1901 with vorolanib for maintenance of nAMD
DAVIO Trial Results: Vorolanib Injection Reduces Treatment Burden for Patients with nAMD

53% of participants didn’t need anti-VEGF for six months or longer

Ad